JPMorgan Chase & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$106M Buy
4,353,952
+920,430
+27% +$22.4M 0.01% 844
2025
Q1
$71.3M Buy
3,433,522
+641,951
+23% +$13.3M 0.01% 999
2024
Q4
$65.7M Sell
2,791,571
-163,708
-6% -$3.85M ﹤0.01% 1034
2024
Q3
$75.7M Buy
2,955,279
+699,901
+31% +$17.9M 0.01% 993
2024
Q2
$53M Buy
2,255,378
+1,124,827
+99% +$26.4M ﹤0.01% 1111
2024
Q1
$32.5M Buy
1,130,551
+797,006
+239% +$22.9M ﹤0.01% 1404
2023
Q4
$10.9M Buy
333,545
+104,276
+45% +$3.42M ﹤0.01% 2039
2023
Q3
$6.39M Buy
229,269
+35,724
+18% +$995K ﹤0.01% 2278
2023
Q2
$6.6M Buy
193,545
+8,712
+5% +$297K ﹤0.01% 2323
2023
Q1
$5.56M Buy
184,833
+168,398
+1,025% +$5.06M ﹤0.01% 2368
2022
Q4
$464K Sell
16,435
-1,452
-8% -$41K ﹤0.01% 3800
2022
Q3
$588K Buy
17,887
+2,633
+17% +$86.6K ﹤0.01% 3649
2022
Q2
$480K Sell
15,254
-220,225
-94% -$6.93M ﹤0.01% 3907
2022
Q1
$10.8M Sell
235,479
-219,773
-48% -$10.1M ﹤0.01% 1971
2021
Q4
$27.9M Buy
455,252
+75,140
+20% +$4.6M ﹤0.01% 1354
2021
Q3
$28.4M Buy
380,112
+41,365
+12% +$3.09M ﹤0.01% 1338
2021
Q2
$31.3M Buy
338,747
+20,895
+7% +$1.93M ﹤0.01% 1330
2021
Q1
$28.2M Buy
317,852
+224,948
+242% +$20M ﹤0.01% 1349
2020
Q4
$8.66M Buy
92,904
+84,565
+1,014% +$7.89M ﹤0.01% 2013
2020
Q3
$535K Sell
8,339
-5,269
-39% -$338K ﹤0.01% 3356
2020
Q2
$709K Buy
13,608
+2,947
+28% +$154K ﹤0.01% 3171
2020
Q1
$334K Buy
10,661
+2,438
+30% +$76.4K ﹤0.01% 3491
2019
Q4
$276K Buy
+8,223
New +$276K ﹤0.01% 3707